- Exchange: New York
- Sector: Consumer, Non-cyclical
- Industry: Healthcare-Products
- Sub-Industry: Medical Products
Becton Dickinson and Co
Add to PortfolioBDX:US
74.4200 USD 0.3000 0.40%As of 20:04:06 ET on 05/25/2012.
Snapshot for Becton Dickinson and Co (BDX)
| Open: | 74.7500 | Day's Range: | 74.1700 - 74.9300 | Volume: | 925,395 | Bid: | 74.3700 |
|---|---|---|---|---|---|---|---|
| Previous Close: | 74.7200 | 52wk Range: | 69.5900 - 89.7500 | 1-Yr Rtn: | -12.59% | Ask: | 74.4000 |
Key Statistics for BDX
| Current P/E Ratio (ttm) | 13.7306 |
|---|---|
| Estimated P/E (09/2012) | 13.0584 |
| Earnings Per Share (USD) (ttm) | 5.4200 |
| Est. EPS (USD) (09/2012) | 5.6990 |
| Est. PEG Ratio | 1.6323 |
| Market Cap (M USD) | 15,084.95 |
| Shares Outstanding (M) | 202.70 |
| Enterprise Value (M USD) (ttm) | 17,143.37 |
| Enterprise Value/EBITDA (ttm) | 7.79 |
| Price/Book (mrq) | 3.3700 |
| Price/Sale (ttm) | 2.0052 |
| Dividend Indicated Gross Yield | 2.4194 |
| Next Earnings Announcement | 08/02/2012 |
More BDX Key Statistics
mrq = Most Recent Quarter; ttm = Trailing Twelve Months
Financials for BDX
- Operating
- Investing
- Financing (M/USD)
Company Profile & Key Executives for BDX
Becton, Dickinson and Company is a global medical technology company engaged principally in the development, manufacture and sale of medical devices, instrument systems and reagents used by healthcare institutions, life science researchers, clinical laboratories, the pharmaceutical industry and the general public.
| Edward J Ludwig "Ed"Chairman | Vincent A ForlenzaPresident/CEO |
| David V ElkinsExec VP/CFO | William A KozyExec VP |
Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.
Sponsored Links
Top Forex Trading Resources
Advertisement
Advertisement
Advertisements
Rate this Page